Clinical trial Recruiting at 1 site Interventional Ages 18 to 41 Women only

Exploring how paternal age affects sperm selection in IVF

Official title: The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture

Run by Reproductive Medicine Associates of New Jersey · NCT06629766 · Data updated 2026-11-12

This study tests if using a new sperm selection device helps men of different ages have better success with IVF compared to the traditional method.

Quick facts

Study typeInterventional
Ages18 Years to 41 Years
SexWomen only
Enrollment100 (estimated)
SponsorReproductive Medicine Associates of New Jersey
Academic / other
Locations1 site (Basking Ridge, New Jersey)
StatusRecruiting
StartedApril 9, 2025
Main results expectedJanuary 2027
Study endsDecember 2028
Registry record updatedJune 3, 2026
Trial IDNCT06629766 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are couples undergoing their first IVF cycle with specific criteria regarding female age, ovarian reserve, and embryo quality.

Probably not a fit

Patients with male partners who have azoospermia, oligozoospermia, or other significant sperm quality issues may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of paternal age on sperm quality and reproductive success in patients undergoing in vitro fertilization (IVF). It compares the effectiveness of a microfluidic sperm selection device (Zymot) against the traditional density gradient centrifugation method for preparing sperm for intracytoplasmic sperm injection (ICSI). The study will assess various embryology parameters, including DNA fragmentation and clinical pregnancy outcomes, in a randomized control trial format. Participants will be monitored throughout their IVF cycle to evaluate the outcomes of using different sperm preparation techniques.

Why it matters

Potential benefit: If successful, this study could enhance IVF success rates by optimizing sperm selection methods based on paternal age.

How similar studies have gone: While there have been studies on sperm selection methods, this specific approach considering paternal age is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Undergoing first IVF cycle
* Electing single embryo transfer
* Electing PGT-A of their embryos
* Female partners age \<42 years old at start of VOR cycle, but \>18 years old.
* AMH ≥ 1.2 ng/mL
* AFC ≥ 8
* FSH ≤ 12IU/L
* At least 4 mature oocytes (M2s) retrieved at the VOR procedure in order to randomize
* Intention to transfer the morphological best quality, euploid, embryo at the frozen embryo transfer procedure

Exclusion Criteria:

* Contraindication to IVF
* Clinical indication for preimplantation genetic testing (i.e., screening for single gene disorder, chromosomal translocation, or any other disorders requiring a more detailed embryo genetic analysis)
* Male partner with azoospermia or oligozoospermia (\<500,000 total motile spermatozoa on the most recent semen analysis within one year of enrollment)
* Planned for previously cryopreserved sperm to be used for ICSI
* Donor sperm
* Male partner with Y-chromosome microdeletion
* Male partner with any Karyotype other than 46,XY
* Male partner requiring surgically obtained sperm either via testicular or epididymal retrieval procedures
* Uncorrected hydrosalpinges that communicate with the endometrial cavity
* Endometrial Insufficiency, as defined by a prior cycle with maximal endometrial thickness \<6mm,), or persistent endometrial fluid
* Donor oocyte or embryo cycles
* Gestational carriers

Where it's running

  • Reproductive Medicine Associates of New Jersey
    Basking Ridge, New Jersey, United States
    Recruiting

Study contacts

  • Principal investigator: Kassie Bollig, MD, MSCE — Reproductive Medicine Associates of New Jersey
  • Study coordinator: Caroline Clinical Research Nurse, BSN, RN
  • Email: clinicalresearchteam@ivirma.com
  • Phone: 973-656-2841

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.